Resources Contact Us Home
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/234.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.)
Description: Subject matter involving a bacterium, a component of a bacterium, or a substance produced by a bacterium.

Sub-classes under this class:

Class Number Class Name Patents
424/246.1 Bacillus 145
424/253.1 Bordetella (e.g., bordetella bronchiseptica, etc.) 84
424/252.1 Brucella (e.g., brucella abortus, brucella canis, etc.) 37
424/263.1 Chlamydia (e.g., chlamydia trachomatis, etc.) 125
424/247.1 Clostridium (e.g., clostridium tetani, clostridium difficile, clostridium perfringens, clostridium botulinum, clostridium chauvoei, etc.) 222
424/245.1 Corynebacterium (e.g., corynebacterium diphtheriae, etc.) 54
424/257.1 Escherichia (e.g., escherichia coli, etc.) 188
424/256.1 Hemophilus (e.g., hemophilus influenzae, hemophilus gallinarum, hemophilus pleuropnemoniae, etc.) 236
424/259.1 Klebsiella (e.g., klebsiella pneumoniae, etc.) 39
424/251.1 Moraxella (e.g., moraxella bovis, etc.) 70
424/248.1 Mycobacterium (e.g., mycobacterium tuberculosis, calmette-guerin bacillus (i.e., bcg), etc.) 425
424/264.1 Mycoplasma 68
424/249.1 Neisseria (e.g., neisseria gonorrhoeae, etc.) 139
424/255.1 Pasteurella (e.g., pasteurella multocida, pasteurella hemolytica, etc.) 109
424/242.1 Pilus, fimbria, or adhesin 95
424/260.1 Pseudomonas (e.g., pseudomonas aeruginosa, etc.) 121
424/258.1 Salmonella (e.g., salmonella typhimurium, etc.) 193
424/243.1 Staphylococcus (e.g., staphylococcus aureus, etc.) 184
424/244.1 Streptococcus (e.g., group b streptococcus, pneumococcus or streptococcus pneumoniae, etc.) 422
424/236.1 Toxin or toxoid, except endotoxin (e.g., exotoxin, enterotoxin, etc.) 540
424/235.1 Transposon mutant or deletion mutant bacterium (e.g., produced by transposon mutagenesis, etc.) 128
424/262.1 Treponema (e.g., treponema hyodysenteriae, treponema pallidum, etc.) 47
424/261.1 Vibrio (e.g., vibrio cholera, etc.) 106

Patents under this class:

Patent Number Title Of Patent Date Issued
8709436 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use Apr. 29, 2014
8703153 Salmonella vectored vaccines against Chlamydia and methods of use Apr. 22, 2014
8703151 Tuberculosis vaccines comprising antigens expressed during the latent infection phase Apr. 22, 2014
8703150 Methods of using Bacillus anthracis protective antigen sequences for vaccination Apr. 22, 2014
8703148 Immunogenic composition Apr. 22, 2014
8691243 Protein-based Streptococcus pneumoniae vaccine Apr. 8, 2014
8691237 Brucella abortus proteins and methods of use thereof Apr. 8, 2014
8685415 Mycobacterium mutants for vaccines with improved protective efficacy Apr. 1, 2014
8685413 Heterologous protection against Pasteurella multocida provided by P. multocida fur cells and the outer-membrane protein extracts thereof Apr. 1, 2014
8679510 Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia Mar. 25, 2014
8673550 MSP nanopores and related methods Mar. 18, 2014
8673320 Metal-citrate transporter antigen from Streptomyces coelicolor and uses thereof Mar. 18, 2014
8673312 Method for one-step purification of recombinant Helicobacter pylori neutrophil-activating protein Mar. 18, 2014
8673311 Bacterial spore having therapeutic agent adsorbed on its surface Mar. 18, 2014
8663654 Polysaccharide vaccine for staphylococcal infections Mar. 4, 2014
8663644 Augmentation of titer for vaccination in animals Mar. 4, 2014
8658136 Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response Feb. 25, 2014
8652489 Therapeutic composition with a botulinum neurotoxin Feb. 18, 2014
8647643 Farnesoid-X-receptor antagonist as a vaccine adjuvant Feb. 11, 2014
8647642 Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatment Feb. 11, 2014
8647640 Vaccine compositions and methods of use to protect against infectious disease Feb. 11, 2014
8647639 Cosmetic neurotoxin compositions and methods Feb. 11, 2014
8647636 Low antigen-dose immunization utilizing overlapping peptides for maximizing T-helper cell 1 (Th1) immunity against a pathogen Feb. 11, 2014
8647634 Recombinant avian infectious coryza vaccine and process for preparing same Feb. 11, 2014
8642048 Multiple antigenic peptides immunogenic against Streptococcus pneumonia Feb. 4, 2014
8642047 Non-protein stabilized Clostridial toxin pharmaceutical compositions Feb. 4, 2014
8642042 Protein matrix vaccines and methods of making and administering such vaccines Feb. 4, 2014
8642011 Tuberculosis vaccine Feb. 4, 2014
8637050 Peptide vaccines against group A streptococci Jan. 28, 2014
8637049 Attenuated live vaccines for aquatic animals Jan. 28, 2014
8637048 Immunizing compositions and methods of use Jan. 28, 2014
8637047 Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same Jan. 28, 2014
8637041 Secreted Campylobacter flaggella coregulated proteins as immunogens Jan. 28, 2014
8637001 Anti-obesity agent and anti-obesity food Jan. 28, 2014
8637000 Anti-obesity agent and anti-obesity food Jan. 28, 2014
8636979 TLR 4 and 9 receptors agonists for preventing septic complications of post-traumatic immunodepression in patients hospitalized for severe traumatic injuries Jan. 28, 2014
8632801 Stable therapeutic formulations Jan. 21, 2014
8632784 Nucleic acids and proteins from Streptococcus pneumoniae Jan. 21, 2014
8629100 Method of inhibiting clostridium difficile by administration of oritavancin Jan. 14, 2014
8628947 Potomac horse fever isolates Jan. 14, 2014
8628809 Method of inducing mucosal immune response to antigen with Dioscorea polysaccharides adjuvant Jan. 14, 2014
8628766 Vaccine for protection against Streptococcus suis bacteria of various serotypes Jan. 14, 2014
8623609 Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents Jan. 7, 2014
8623383 Recombinant antigens for diagnosis and prevention of spotted fever rickettsiae Jan. 7, 2014
8623380 Acellular pertussis vaccine with diphthriae- and tetanus-toxoids Jan. 7, 2014
8623376 Chimeric OspA genes, proteins, and methods of use thereof Jan. 7, 2014
8623375 Chimeric OspA genes, proteins, and methods of use thereof Jan. 7, 2014
8617571 Suture line administration technique using botulinum toxin Dec. 31, 2013
8617536 Prevotella histicola preparations and the treatment of autoimmune conditions Dec. 31, 2013
8609350 Anaplasma phagocytophilum (Aph) antigens and antibodies specific for Anaplasma Dec. 17, 2013

  Recently Added Patents
Method for selective deposition of a semiconductor material
System and method for the analysis of biodiesel
Silicas and alkali metal salt compositions, detergents formed from such compositions and method of forming such compositions and detergents
Electronic time stamping apparatus for use with an inground transmitter
Method for providing interactive site map
Epoxy composition for encapsulating an optical semiconductor element
OFDM control signaling in the presence of timing asynchronization in a peer-to-peer network
  Randomly Featured Patents
Automatic equalizer initialization time control for multipoint networks
Internal combustion engine with by-pass control system for supercharger
Transdermal perfusion of fluids
Pool alarm
Snap-in rotatable sprinkler
Waste removal apparatus
Inertia brake
Liquid silicone rubber coating composition, curtain airbag, and its production method
Wheel drive for tracked vehicles
Method for sample identification in a mammal as well as a kit for performing this method